MAPRE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.070200E-01
Normal-vs-Stage2
9.899600E-01
Normal-vs-Stage3
3.664000E-01
Normal-vs-Stage4
1.473210E-01
Stage1-vs-Stage2
6.837000E-01
Stage1-vs-Stage3
3.443200E-01
Stage1-vs-Stage4
2.536400E-02
Stage2-vs-Stage3
2.493600E-01
Stage2-vs-Stage4
2.733800E-01
Stage3-vs-Stage4
6.273800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.430200E-01
Normal-vs-AfricanAmerican
3.127400E-01
Normal-vs-Asian
4.839000E-01
Caucasian-vs-AfricanAmerican
2.494400E-01
Caucasian-vs-Asian
2.768800E-01
AfricanAmerican-vs-Asian
3.702400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.068600E-01
Normal-vs-Female
9.477000E-01
Male-vs-Female
7.092800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.900000E-01
Normal-vs-Age(41-60Yrs)
4.665200E-01
Normal-vs-Age(61-80Yrs)
9.354200E-01
Normal-vs-Age(81-100Yrs)
6.430000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.343600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.348400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.820200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.294170E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.896500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.519400E-01
Normal-vs-Daily Drinker
7.211800E-01
Normal-vs-Weekly Drinker
9.843800E-01
Normal-vs-Occasional Drinker
5.773400E-01
Normal-vs-Social Drinker
7.838600E-01
Non Drinker-vs-Daily Drinker
6.493000E-01
Non Drinker-vs-Weekly Drinker
3.264800E-01
Non Drinker-vs-Occasional Drinker
2.299600E-02
Non Drinker-vs-Social Drinker
1.105230E-01
Daily Drinker-vs-Weekly Drinker
5.780800E-01
Daily Drinker-vs-Occasional Drinker
8.228100E-02
Daily Drinker-vs-Social Drinker
2.608600E-01
Weekly Drinker-vs-Occasional Drinker
3.198400E-01
Weekly Drinker-vs-Social Drinker
6.284200E-01
Occasional Drinker-vs-Social Drinker
6.096400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.333800E-01
Normal-vs-Grade 2
8.059400E-01
Normal-vs-Grade 3
7.961200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.416200E-01
Grade 1-vs-Grade 3
8.149400E-01
Grade 1-vs-Grade 4
6.333800E-01
Grade 2-vs-Grade 3
8.267400E-01
Grade 2-vs-Grade 4
8.059400E-01
Grade 3-vs-Grade 4
7.961200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.038600E-01
Normal-vs-NonDiabetic
9.389200E-01
Diabetic-vs-NonDiabetic
3.778800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.626400E-01
Normal-vs-NoPancreatitis
9.811200E-01
Pancreatitis-vs-NoPancreatitis
9.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.400000E-01
Normal-vs-N1
9.807800E-01
N0-vs-N1
4.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.837200E-01
Normal-vs-TP53-NonMutant
9.024200E-01
TP53-Mutant-vs-TP53-NonMutant
3.795200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
